APTAMER GROUP PLC Logo

APTAMER GROUP PLC

Develops custom aptamer-based binders as antibody alternatives for life science applications.

APTA | IL

Overview

Corporate Details

ISIN(s):
GB00BNRRP542
LEI:
213800Y4XGH3WJNBE686
Country:
United Kingdom
Address:
WINDMILL HOUSE, YO10 5BR YORK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Aptamer Group PLC is a leading developer of custom affinity binders for the life sciences industry through its proprietary Optimer® platform. Optimer binders are next-generation, aptamer-based synthetic ligands engineered to provide high affinity, specificity, and stability. The company offers custom discovery and development services, delivering innovative solutions that serve as alternatives to traditional binders like antibodies. These solutions are utilized across a wide range of applications, including therapeutics, diagnostics, research, and bioprocessing, supporting a global client base of biotechnology and pharmaceutical companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-14 08:00
Earnings Release
Full Year Results for the 12mths to 30 June 2025
English 640.3 KB
2025-10-13 08:00
Regulatory News Service
New contract with top 10 pharma
English 15.7 KB
2025-10-10 08:00
Report Publication Announcement
Notice of Results, Analyst & Investor Presentation
English 13.3 KB
2025-09-11 08:00
Regulatory News Service
New contract with Metir plc
English 17.0 KB
2025-09-09 08:00
Director's Dealing
Notification of dealings by a director/PDMR
English 23.8 KB
2025-09-02 08:00
Regulatory News Service
Therapeutic development agreement with Invizius
English 18.4 KB
2025-08-28 08:00
Share Issue/Capital Change
Block Listing Interim Review
English 14.9 KB
2025-08-22 08:00
Regulatory News Service
Update on licensing and development progress
English 19.5 KB
2025-08-19 08:00
Share Issue/Capital Change
Exercise of warrants
English 13.5 KB
2025-08-18 08:00
Regulatory News Service
Contract extension with global pharma partner
English 14.7 KB
2025-08-08 08:00
Report Publication Announcement
Investor Technical Webinar
English 13.0 KB
2025-08-07 18:24
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
English 52.2 KB
2025-08-05 09:05
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-07-31 14:29
Regulatory News Service
Investor Webinar
English 13.7 KB
2025-07-31 08:00
Earnings Release
Trading Update
English 21.0 KB

Automate Your Workflow. Get a real-time feed of all APTAMER GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for APTAMER GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for APTAMER GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE
Israel HRON

Talk to a Data Expert

Have a question? We'll get back to you promptly.